BioNTech “BioNTainers” Arrive in Rwanda

Presently, 99% of the vaccines that Africa as a continent uses, are manufactured outside of Africa. However, German biotechnology company, BioNTech, is seeking to change that. In June 2022 the ground was broken for a fully modernized mRNA vaccine manufacturing facility in Kigali, the Rwandan capital, which will be the very first mRNA manufacturing plant in the entire continent. And now on March 13th 2023, exactly 3 years after the first Covid-19 case was detected in Rwanda, the "BioNTainer" has arrived in Rwanda, a very important step in making the facility operational. Rwanda's manufacturing plant is to be operational within a year now that the BioNTainers have arrived, and will staff 100 people by 2024.